Biosino Bio-Technology and Science Incorporation (HKG:8247)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.43
+0.03 (0.56%)
At close: Mar 6, 2026
Market Cap785.76M +775.8%
Revenue (ttm)246.61M -20.7%
Net Income-51.86M
EPS-0.36
Shares Out144.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume72,000
Average Volume195,203
Open5.40
Previous Close5.40
Day's Range5.37 - 5.50
52-Week Range0.26 - 7.00
Beta-0.04
RSI57.46
Earnings DateMar 30, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a a strategic cooperation agreeme... [Read more]

Sector Healthcare
Founded 1988
Employees 471
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8247
Full Company Profile

Financial Performance

In 2024, HKG:8247's revenue was 263.07 million, a decrease of -9.00% compared to the previous year's 289.07 million. Losses were -42.53 million, 265.1% more than in 2023.

Financial numbers in CNY Financial Statements